baber/WOPTO huggingface dataset:
Patent NZ-713181-A (NZ)
Title: Improved mixing syringe assembly
Inventor: ANDERSON IAN
IPC: A61M5/315
Filed: 2014-03-26
Abstract: Known prior art syringe arrangements do not permit fluid communication between two adjacent chambers in response to an increase in pressure in either chamber. As a result, known prior art arrangements do not permit the successive forward and rearward movement of the stopper to facilitate effective mixing of ingredients contained in the two chambers. Disclosed herein is a syringe assembly comprising a barrel for containing one or more medicaments, the barrel having a front outlet for allowing the expulsion of said one or more medicaments from the said barrel through said outlet, and a first stopper disposed in the barrel and axially moveable therein and defining a first volume in the barrel axially forwards of the first stopper and a second volume in the barrel axially rearwards of the first stopper. The first stopper has a two way valve that is moveable between a sealing configuration and an open configuration to selectively put the first volume in fluid communication with the second volume. The two way valve is moveable from the sealing configuration to the open configuration by an increase in fluid pressure in either of the first and second volumes. The syringe assembly additionally comprises a second stopper disposed in the barrel axially rearward of the first stopper and axially moveable therein, the second stopper providing a fluid tight seal at a rear end of the second volume. The syringe assembly further comprises a first plunger rod connected to the first stopper and extending axially rearwardly through the second stopper, the second stopper sealingly engaging with the first plunger rod but permitting axial sliding of the first plunger rod therethrough. The syringe assembly further comprises a second plunger rod connected to the second stopper, so as to axially move the second stopper when the second plunger rod is axially moved. The first plunger rod is axially moveable so as to axially move the first stopper and pressurise either of the first volume and second volume causing the two way valve to move into the open configuration and fluidly connect the first volume and second volume.
Patent NZ-715053-A (NZ)
Title: Anti-obesity potential of calebin a
Inventor: NAGABHUSHANAM KALYANAM
IPC: A61P3/04
Filed: 2014-06-10
Abstract: Disclosed is the use of Calebin A also known as (3E)-4-(4-Hydroxy-3-methoxyphenyl)-2-oxo-3-buten-1-yl (2E)-3-(4-hydroxy-3-methoxyphenyl)acrylate in the manufacture of a medicament for obesity management and physiological factors thereof such as inhibiting adipogenesis and increasing expression of adiponectin.
Patent NZ-716577-A (NZ)
Title: Identification assembly for an identity document
Inventor: VAN DEN BERG JAN
IPC: B42D25/435
Filed: 2014-07-23
Abstract: The invention relates to an identification assembly for an identity document (10) comprising a substrate (12) with a substantially planar configuration, and an adjacent surface (13, 14) hingeably attached to the substrate (12) and provided adjacent to the substrate (12). The substrate (12) comprises at least two image areas (18, 20), a first image area (18) having a first image (19), and wherein the substrate comprises a second image area (20) comprising a second laser produced image (21), and a third image(22) corresponding to the second image (21) is provided through the second image area (20) onto the adjacent surface (13, 14), the third image (22) being visible for a user by hinging the substrate away from the adjacent surface (14). Fig. 2a. By having the third image applied onto the adjacent surface through the second image area in the substrate unauthorised exchange of the holder page becomes more difficult than if only images were provided onto the holder page in the identity document.
Patent NZ-728679-A (NZ)
Title: Flexible body armor
Inventor: BECK JASON
IPC: F41H5/04
Filed: 2017-01-30
Abstract: The present invention relates to ballistic filler for flexible body armor and more particularly to ballistic filler comprising a woven fabric stitched to unidirectional laminates and methods of manufacturing the same. Implementations described and claimed herein provide a ballistic filler for a flexible soft body armor and methods of manufacturing the same. Typically, the ballistic filler of conventional ballistic gear achieves a compromise in performance at best. More particularly, conventional ballistic filler: improves flexibility at the expense of increased back face deformation; improves back face deformation performance at the expense of flexibility, mechanical fatigue resistance, and fragmentation threat resistance; or improves durability and ballistic performance at the expense of slip and translation resistance during a ballistic impact. It is with these observations in mind, among others, that various aspects of the present disclosure were conceived and developed. In one implementation of the flexible body armor ballistic filler of the invention, a first portion having a first subpanel is stitched directly to a second subpanel with a stitching pattern. The first subpanel has one or more layers of woven fabric, and the second subpanel has one or more layers of unidirectional fabric. A second portion backs the first portion. The second portion has one or more layers of unstitched unidirectional fabric. The flexible body armor ballistic filler of the invention is able to provide improvement in wearer comfort through low weight, durability, and flexibility. The invention may also provide enhanced resistance to ballistic penetration, back-face deformation, material fatigue, and fragmentation threat.
Patent NZ-729408-A (NZ)
Title: A method of photochemical internalization (pci) utilizing a antigenic molecule, a photosensitizing agent, and a cytokine
Inventor: HØGSET ANDERS
IPC: A61K41/00
Filed: 2015-08-28
Abstract: The present invention provides a method of expressing an antigenic molecule or a part thereof on the surface of a cell using a photochemical internalisation method in which GM-CSF cytokine, is used to enhance the method. The method may be used to stimulate an immune response and for various therapeutic or prophylactic methods. Pharmaceutical compositions or kits comprising the components for use in the method, cells produced by the method and their use in therapy and prophylaxis also form aspects of the invention.
Patent NZ-738361-A (NZ)
Title: A device, system and method for vibration sensitivity assessment
Inventor: HICKISH TAMASH FREDERICK GORDON
IPC: A61B5/00
Filed: 2016-05-16
Abstract: A system for clinical vibration sensitivity assessment comprising: a device comprising: an attachment portion configured to detachably clip the device onto a mobile telephone, wherein an internal shape of the attachment portion is configured closely to match an external shape of the mobile telephone; and a probe configured to be applied to a test location on a test subject’s skin and to convey vibrations generated by the mobile telephone to the test location; and the mobile telephone, wherein the mobile telephone is configured to carry out a vibration sensitivity assessment procedure comprising: generating a predetermined intensity of the vibrations; and receiving user input indicating the test subject’s ability to feel the predetermined intensity of vibrations at the test location, wherein the mobile telephone is configured to carry out the vibration sensitivity assessment procedure in iterative steps comprising: performing the generating and receiving steps; increasing the predetermined intensity of the vibrations; and repeating the generating and receiving steps.
Patent NZ-744822-A (NZ)
Title: Multi-depth plane display system with reduced switching between depth planes
Inventor: HARRISES CHRISTOPHER
IPC: G06T19/20
Filed: 2017-02-10
Abstract: Methods and systems for reductions in switching between depth planes of a multi- depth plane display system are disclosed. The display system may be an augmented reality display system configured to provide virtual content on a plurality of depth planes using different wavefront divergence. The system may monitor the fixation points based upon the gaze of each of the user’s eyes, with each fixation point being a three-dimensional location in the user’s field of view. Location information of virtual objects to be presented to the user are obtained, with each virtual object being associated with a depth plane. In some embodiments, the depth plane on which the virtual object is to be presented is modified based upon the fixation point of the user’s eyes. For example, where the user is switching their fixation between virtual objects on two different depth planes, the display system may be configured to modify the presentation of one of the objects such that both objects are placed on the same depth plane.
Patent NZ-750950-A (NZ)
Title: Omecamtiv mecarbil and salts thereof and their uses
Inventor: BI MINGDA
IPC: C07D213/75
Filed: 2014-03-14
Abstract: The cardiac sarcomere is the basic unit of muscle contraction in the heart, and is a highly ordered cytoskeletal structure composed of cardiac muscle myosin, actin and a set of regulatory proteins. The discovery and development of small molecule cardiac muscle myosin activators would lead to promising treatments for acute and chronic heart failure. Cardiac muscle myosin is the cytoskeletal motor protein in the cardiac muscle cell. It is directly responsible for converting chemical energy into the mechanical force, resulting in cardiac muscle contraction. Current positive inotropic agents, such as beta-adrenergic receptor agonists or inhibitors of phosphodiesterase activity, increase the concentration of intracellular calcium, thereby increasing cardiac sarcomere contractility. However, the increase in calcium levels increase the velocity of cardiac muscle contraction and shortens systolic ejection time, which has been linked to potentially life-threatening side effects. In contrast, cardiac muscle myosin activators work by a mechanism that directly stimulates the activity of the cardiac muscle myosin motor protein, without increasing the intracellular calcium concentration. They accelerate the rate-limiting step of the myosin enzymatic cycle and shift it in favour of the force-producing state. Rather than increasing the velocity of cardiac contraction, this mechanism instead lengthens the systolic ejection time, which results in increased cardiac muscle contractility and cardiac output in a potentially more oxygen-efficient manner. Omecamtiv mecarbil is a first in class direct activator of cardiac myosin, the motor protein that causes cardiac contraction. It is being evaluated as a potential treatment of heart failure in both intravenous and oral formulations with the goal of establishing a new continuum of care for patients in both the in-hospital and outpatient settings. Clinical trials providing an I.V. delivery of omecamtiv mecarbil have shown that plasma levels of the drug can be delivered safely and effectively. However, standard release formulations and some extended release formulations gave peak to trough ratios that may be too great to provide a safe and effective amount of omecamtiv mecarbil to patients who need the drug in a chronic or preventative setting. Accordingly, an effective sustained release formulation would be desirable for increased patient safety and effectiveness. Therefore, in one embodiment, there is provided a pharmaceutical formulation comprising omecamtiv mecarbil, or a pharmaceutically acceptable salt, a pharmaceutically acceptable hydrate, or a pharmaceutically acceptable hydrate of a pharmaceutically acceptable salt thereof, such as a dihydrochloride monohydrate salt of omecamtiv mecarbil.
Patent PT-106217-A (PT)
Title: Sistema de interação de equipamentos remotos em centros emissores de radiodifusão
Inventor: PEREIRA RUI PAULO FERNANDES
IPC: H04H20/20
Filed: 2012-03-16
Abstract: O PRESENTE INVENTO REFERE-SE A UM SISTEMA PARA ATUAR E MONITORIZAR REMOTAMENTE ESTAÇÕES DE RADIODIFUSÃO. A SUA ARQUITETURA, BASEADA NUM DISPOSITIVO ELETRÓNICO PROGRAMÁVEL COM CONECTIVIDADE AO EXTERIOR POR INTERMÉDIO DE RADIOFREQUÊNCIA, TORNA A INVENÇÃO COMPLETAMENTE INDEPENDENTE DE EQUIPAMENTOS PERIFÉRICOS E PERMITE A MONITORIZAÇÃO E O CONTROLO REMOTO DOS CENTROS EMISSORES DE RADIODIFUSÃO A PARTIR DE UM TERMINAL MÓVEL (E.G. TELEMÓVEL). OS EQUIPAMENTOS EXISTENTES NO MERCADO APENAS CONSIDERAM, POR CONSTRUÇÃO, UM SENTIDO DE INTERAÇÃO: OU ATUAM NO CENTRO EMISSOR OU MONITORIZAM O CENTRO EMISSOR. O SISTEMA APRESENTADO NESTE DOCUMENTO PERMITE ATUAR REMOTAMENTE NOS CENTROS DE RADIODIFUSÃO E PERMITE RECEBER MONITORIZAÇÃO AUTOMÁTICA DE ALARMES OU INFORMAÇÕES DO ESTADO DO CENTRO DE RADIODIFUSÃO. ESTE EQUIPAMENTO COMPREENDE UMA ESTRUTURA QUE PARTINDO DE UM MICROPROCESSADOR (1) GERE UM CONJUNTO DE PERIFÉRICOS (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 E 13) EM ATUAÇÃO E MONITORIZAÇÃO. O MODEM DE RADIOFREQUÊNCIA (2) ESTABELECE A COMUNICAÇÃO ENTRE O TERMINAL REMOTO (E.G. TELEMÓVEL) E O SISTEMA ALARMBOX. UM MOSTRADOR ELETRÓNICO (3) PERMITE VISUALIZAR NO LOCAL O ESTADO DO SISTEMA. UM CIRCUITO INTEGRADO (4) ESPECIALIZADO NA RECEÇÃO E NA DESMODULAÇÃO DE SINAIS DE RÁDIO, NAS BANDAS COMERCIAS ASSOCIADAS ÀS SIGLAS FM (FREQUENCY MODULATION), AM (AMPLITUDE MODULATION), SW (SHORT WAVE), LW (LONG WAVE), ESTÁ CONECTADO AO MICROPROCESSADOR (1) E AO MODEM DE RADIOFREQUÊNCIA (2). ESTA ASSOCIAÇÃO PERMITE SINTONIZAR ESTE RECETOR REMOTAMENTE, REALIZAR A ANÁLISE AUTOMÁTICA DO SINAL DE ÁUDIO LOCALMENTE E ENVIAR O SINAL DE ÁUDIO PARA ANÁLISE REMOTA VIA MODEM DE RADIOFREQUÊNCIA (2). AO MICROPROCESSADOR ESTÁ CONECTADO UM ÓRGÃO DE ARMAZENAMENTO PERMANENTE DE DADOS (5) COM A FINALIDADE DE REGISTAR OS ESTADOS SUCESSIVOS DO SISTEMA, PARA EVENTUAL POSTERIOR ANÁLISE. EXISTE NO SISTEMA UM BLOCO DE INTERFACE DE ENTRADAS DE TENSÕES EXTERNAS (6) E UM BLOCO DE INTERFACE DE SAÍDAS PARA ATUAÇÃO EXTERNA (7). ESTAS INTERF ACES (6, 7) SÃO GERIDAS LOCALMENTE E/OU REMOTAMENTE. O SISTEMA POSSUI UMA FONTE COMUTADA DE ALIMENTAÇÃO EM TENSÃO (9) CONTÍNUA PARA O FORNECIMENTO DE ENERGIA AO CONJUNTO DE DISPOSITIVOS DO SISTEMA. EXISTE UMA UNIDADE DE BOTÕES (10) LOCAIS PARA INTERVENÇÕES DIRETAS AO SISTEMA, UM SENSOR DE TEMPERATURA AMBIENTE (11), UM TRANSDUTOR ACÚSTICO (12), E UM CANAL DE COMUNICAÇÃO LOCAL USB (UNIVERSAL SERIAL BUS)(13). O MICROPROCESSADOR (1) REALIZA CONTINUAMENTE UMA OPERAÇÃO DE ANÁLISE AO SINAL DE ÁUDIO PROVENIENTE DO CIRCUITO INTEGRADO RECETOR DE ÁUDIO (4). ESTA ANÁLISE ESTÁ BASEADA EM ESTATÍSTICA DE 2.ª ORDEM E ESTABELECE O DESIGNADO DETETOR DE SILÊNCIO (8).
Patent PT-109308-A (PT)
Title: Método gráfico de avaliação e de comparação de planos dosimétricos de radioterapia
Inventor: BRÍGIDA DA COSTA FERREIRA
IPC: A61N5/10
Filed: 2016-04-07
Abstract: A PRESENTE INVENÇÃO REFERE-SE A UM MÉTODO GRÁFICO DE AVALIAÇÃO E COMPARAÇÃO DE PLANOS DE RADIOTERAPIA. A PARTIR DA CATEGORIZAÇÃO DAS ESTRUTURAS EM GRUPOS COM PESOS RELATIVOS E A DEFINIÇÃO DE PONTUAÇÕES CALCULADAS A PARTIR DE CRITÉRIOS DOSIMÉTRICOS, VOLUMÉTRICOS OU RADIOBIOLÓGICOS SÃO GERADOS GRÁFICOS DE RADAR PERSONALIZADOS, QUE PERMITEM AFERIR SE TODAS AS CONDIÇÕES DOSIMÉTRICAS DEFINIDAS PELO RADIONCOLOGISTA NA PRESCRIÇÃO DO TRATAMENTO FORAM CUMPRIDAS E COMPARAR DE FORMA OBJETIVA DIFERENTES PLANOS. PARA CADA PLANO SÃO TAMBÉM CALCULADAS PONTUAÇÕES GLOBAIS, DETERMINADAS A PARTIR DA SOMA PONDERADA DAS PONTUAÇÕES DE CADA ESTRUTURA OU GRUPO. DESTA FORMA, O PRESENTE MÉTODO CONSTITUI-SE COMO UMA IMPORTANTE FERRAMENTA DE SUPORTE À DECISÃO NA ESCOLHA DO MELHOR PLANO DE TRATAMENTO. A PRESENTE INVENÇÃO PODE SER FACILMENTE INTEGRÁVEL EM SISTEMAS DE PLANEAMENTO, EM SOFTWARE DE REGISTO E DELINEAMENTO DE ESTRUTURAS E DE ANÁLISE E COMPARAÇÃO DE PLANOS DOSIMÉTRICOS.
Patent RO-79500-A (RO)
IPC: C07D295/20
Filed: 1980-03-26
Abstract: The m-Cyanoalkoxy-phenylureas of the formula I    <IMAGE>  (I) wherein X is hydrogen or halogen, Y-O is a preferably branched-chain cyanoalkoxy group, and -NR1R2 is a primary, secondary or heterocyclic amino group, exhibit surprisingly good herbicidal activity against mono- and dicotyledonous plants, with a selective action in crops of maize, cereals, cotton and soya bean, and in the case of some of these compounds also in rape crops.
Patent RU-94033057-A (RU)
Inventor: BASHMAKOV A K
IPC: F42D5/04
Filed: 1994-09-05
Abstract: FIELD: disposal of explosive devices by mechanical destruction without initiation of explosion. SUBSTANCE: destruction is accomplished by explosive and/or fragmentation effect after explosion of a destructive explosive device with direction of the shock wave at an angle of 90 to 45 deg. relative to the detonator axis and up to 45 deg. relative to the explosive axis with an explosive mass within 10 to 30 g, but not more than 2% of the explosive mass of the explosive device warhead, the mass of fragments being approximately equal to the explosive mass of the destructive explosive device. The destructive explosive device uses a detonator, charge and fragmentation plate installed in succession in the direction of the explosive device to be destructed in a screening case with a side open in the direction of the explosive device to be destructed and conically diverging side walls; the screening case is formed by the walls of the wave suppressor enveloping it. EFFECT: enhanced safety.
Patent RU-94039143-A (RU)
Inventor: KAGAN A A
IPC: E02B8/06
Filed: 1994-10-14
Abstract: FIELD: hydraulic engineering, hydraulic engineering equipment production. SUBSTANCE: aim is to provide effective damping of stream energy on dam spillway in wide range of water heads. Apparatus has mounted in dam body 1 counter-swirl damper, that is made of several pairs in series connected spiral chambers 2 and 3. The latter have individually feeding pipelines 4 and 5, connected to corresponding chambers tangentially to their cylindrical part and central (axial)) canals. Number of spiral chambers pairs is defined by extremely allowed for one pair normal operation of water stream energy and total and maximum for the hydraulic engineering installation value of water head. EFFECT: apparatus allows to damp effectively stream energy on dam spillway in wide range of water heads. 3 cl, 1 dwg
Patent RU-94039646-A (RU)
Inventor: LASHKOV V G
IPC: B61F1/02
Filed: 1994-10-21
Abstract: FIELD: railway transport. SUBSTANCE: frame has center sill and two side beams interconnected by end, bolster intermediate cross beams. Rigidly secured on bolster beams from the bottom are side bearers and pivot bearing and from the top, tank supports. Rigidly secured on top in middle portion of center sill are pawls holding tank from longitudinal displacement. Frame has four cross stays arranged in pairs between bolster beams and symmetrically relative to frame cross axis. Cross stays of each pair are secured by ends on side beams and by other ends on center sill at angle "Φ" relative to each other. Vertices of angles "Φ" formed by each pair of cross stays are pointed to frame center of gravity. Distance "a" from vertex of angle "Φ" to frame center of gravity and angle "Φ" found from equations: a = L(0.3-0.4)where L-distance between pivot bearing and frame center of gravity; 1 - half of bogie base; B-half of frame outer width. EFFECT: reduced stresses in center sill, increased strength of center sill, enhanced operation reliability. 2 dwg
Patent RU-94044084-A (RU)
Inventor: KHALAEV G G
IPC: F16K5/10
Filed: 1994-12-15
Abstract: FIELD: mechanical engineering. SUBSTANCE: cock may have a conical plug provided with a quick- detachable insert. A connecting pipe and check valve are arranged in the direction of the flow in the passageway made in the insert. EFFECT: enhanced reliability. 2 cl, 2 dwg
Patent RU-94044178-A (RU)
Inventor: KOLOMIJTSEV A K
IPC: A61N5/06
Filed: 1994-12-15
Abstract: FIELD: medicine. SUBSTANCE: method involves exposing patient organism to power quanta. Patient eye retina is subjected to light flux penetrating microscopic tissue slice taken from the corresponding organ and having signs of inflammation and necrosis during 10 min daily or each second day with 10-12 procedures in a course of treatment. EFFECT: enhanced effectiveness of treatment course.
Patent RU-94044442-A (RU)
Inventor: DEHVID F BREHSHIEHRS
IPC: E01C19/10
Filed: 1994-12-13
Abstract: FIELD: construction engineering. SUBSTANCE: inclined counterflow rotating mixer has a torch bit located in the intermediate position between the inlet for aggregate on one end face of the drum and the outlet for asphalt concrete on the opposite end face of the drum. The blower supplies additional air to the torch through the pipe for air with a hole communicating with the mixing chamber positioned between the torch bit and the discharge (outlet) end face of the drum for suction of gases from the mixing chamber so as to provide their flow through the torch flame. Suction builds up negative pressure in the mixing chamber causing a reversible flow of gaseous combustion products from the drying chamber to the mixing chamber for preheated of reused asphalt-containing material fed to the mixing chamber. Besides, reused asphalt-containing material is preheated due to the fact that the preheating chamber is positioned near the flame zone not having a direct contact with flame for preheating of reused asphalt- containing material. Hot and dried non-used aggregate is mixed with reused asphalt-containing material in the preheating chamber; provision is made for valves used to prevent an outlet of gases released from reused asphalt-containing material in the preheating chamber to the drying chamber. EFFECT: enhanced capacity.
Patent RU-94046205-A (RU)
Inventor: GERKHARD ALIKE
IPC: C08J9/12
Filed: 1993-05-26
Abstract: FIELD: polymer processing. SUBSTANCE: plates are manufactured via extrusion of styrene polymer formulation containing 1-10 wt % gaseous foaming agent based on oxygen-containing compound and also, if necessary, special additives, said foaming agent being at least one ether selected from the group including dimethyl ether, methyl ethyl ether, and methyl vinyl ether. Ether may be used in mixture with carbon dioxide and saturated hydrocarbon with 3-5 carbon atoms and/or alcohol boiling within the temperature range 56-100 C. EFFECT: improved quality of produce.
Patent RU-95101254-A (RU)
Inventor: KHAJRULLIN I KH
IPC: A63J15/00
Filed: 1995-01-27
Abstract: FIELD: entertainment, design, production of original pictures. SUBSTANCE: method involves closing eyes; slightly pressing eyeballs by fingers to obtain colored image of pictures movable in kaleidoscopic manner; watching these pictures for five minutes; reproducing seen pictures and colors on paper or other material. EFFECT: increased efficiency in obtaining unusual original pictures or designs. 2 cl
Patent RU-95104033-A (RU)
Inventor: SHCHERBAKOV M G
IPC: E02F9/22
Filed: 1995-03-21
Abstract: FIELD: hydraulic drives of construction and road-building machinery. SUBSTANCE: drive has two hydraulic pumps with delivery hydraulic lines which are connected with directed towards each other flow bores of multispool sectional hydraulic control valve having control spool sections for operation of hydraulic motors of working members (boom, bucket, arm, left-hand crawler, right-hand crawler, steering, reserve), and return hydraulic lines. Control valves in dual-flow hydraulic drive which direct working fluid to hydraulic motors, such as for travel, are provided with additional bores located in each first control valve at pump side in different flow passages. Length of bores meets following relation: L=S+2h+2$$$, where S-thickness of partition in flow passage body; 2h - total displacement of spool in control valve; 2$$$ - total width of slots in flow passage for working fluid. Given innovation simplifies design, enhance operational reliability due to exclusion of additional hydraulic control valve and its actuation system, all "OR" elements with corresponding hydraulic lines, and portion of hydraulic line which connects supply lines of corresponding spool valves. EFFECT: high efficiency.